Navigation Links
Gentiva(R) Health Services Completes Acquisition of Major Home Health Provider in CON State of Mississippi
Date:3/3/2008

MELVILLE, N.Y., March 3 /PRNewswire-FirstCall/ -- Gentiva Health Services, Inc. (Nasdaq: GTIV), the nation's leading provider of comprehensive home health services, announced today that it has completed its acquisition of 100% of the ownership interest in Home Health Care Affiliates, Inc. and certain of its subsidiaries and affiliates (HHCA) for $55 million in cash, subject to post-closing adjustments.

The transaction, which extends Gentiva's home health operations to 37 states, has been funded from a combination of Gentiva's existing cash balances and borrowings from its revolving credit facility. HHCA operates home health and hospice agencies in Mississippi under the brand names of Gilbert's Home Health and Gilbert's Hospice Care. The transaction will be accretive to Gentiva's fiscal 2008 results.

"We extend a warm welcome to all Gilbert's employees and anticipate a smooth transition in delivering our services to home health and hospice patients in the state," said Gentiva Chairman and CEO Ron Malone. "We also look forward to the possibility of bringing our groundbreaking specialty home health programs and other Gentiva services to this region as yet another way to differentiate us from the competition and build strong relationships with physicians and payers."

Annualized 2007 unaudited net revenues for the Gilbert's operations were approximately $37 million, of which approximately $33 million related to home health services and $4 million to hospice services. Gilbert's Home Health and Gilbert's Hospice Care, with approximately 500 employees and a business mix that is approximately 81% Medicare, deliver their services through 14 locations covering 50 of 82 counties in Mississippi, a Certificate of Need state for hom
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Gentiva(R) Health Services to Present March 3rd at Raymond James 29th Annual Institutional Investors Conference in Orlando
2. Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
3. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
4. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
5. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
6. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
7. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
8. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
9. Gentiva(R) Health Services Files Universal Shelf Registration Statement
10. Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans
11. In early childhood, continuous care by 1 doctor improves delivery of health screenings

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...SILVERSPRING,Md.,Nov.25/PRNewswire-USNewswire/--An...erforDrugEvaluationandResearch,titled"ADifficultBa...intheNov.26,2009issueofTheNewEnglandJournalofMedic...rnh/20090824/FDALOGO ) ,, Inthearticle,Woodcock...painmedicationforthosewhoneeditandmanagingtherisks...
(Date:11/25/2009)...erm survivors of testicular cancer who were treate...e side effects, including neurological side effect...t treated with chemotherapy, according to a new st...f the National Cancer Institute . , Marianne Bry... University Hospital, in Bergen, Norway, and colle...
(Date:11/25/2009)...y follow-up period was too short to draw definite ..., Nov. 25 (HealthDay News) -- In diabetic patients...be no difference in outcomes at one year whether p... stenting, British researchers report. , Bypass...tic patients with coronary artery disease. However...
(Date:11/25/2009)...s often plagued by neurological symptoms, study fi...ews) -- Neurological side effects are among the po...esticular cancer who were treated with cisplatin-b... study included 1,409 Norwegian men treated for un...ho took part in a follow-up survey conducted from ...
(Date:11/25/2009)... LittleImprovementShownforthe4thStraightYear ,...day,LungCancerAlliance-Georgia(LCA-GA)issuedthe 4t...smentofprogressbeingmadeagainstthislethaldiseasein...ance(LCA),theonlynationalorganizationdedicatedexcl...ithoratriskforlungcancer. ,, (Logo: http://www....
Breaking Medicine News(10 mins):Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
...of the couch potato may become a reality some day,...cal pathways that// muscle cells use to build stre...e in hand, it now may be possible to develop a pil...et of the study is to promote the health of people...
...lants Camellia sinensis contains polyphenols in th...which gives the tea its antioxidant properties. Po...logical process known as oxidative stress. ...esulting in heart diseases, cancer, cholestrol and...
...ped a computer test which they say has proved 100%... modelled on the human brain,// and has been devis...he system, was developed at the University of Brit...in characteristics in the brain blood flow, which ...
...rist has discovered that treating patients with oe... halucinations.// Although antipsychotic drugs lik...still suffer these. But researchers have s...ally strikes them later in life. Studies in anima...
...nistration began two days of public hearings to de...-counter that currently require a doctor's prescri...d, ranging from blood pressure drugs to birth cont... due, to industry advertising. Pharmaceutical comp...
...rs at the Mayo Clinic, promote a simple form of se...ess. Hypnotherapy can be a great way to break bad ...ain. Its success depends upon why it is being used... simple form of self hypnosis. This involves...
Other Medicine News:
(Date:11/25/2009)...,, COLLEGEPARK,Md.,Nov.25/PRNewswire-USNewswi...havingcream-likefoamthatstopsseverebleeding,wonfir...egoryoftheGlobalSecurityChallenge2009,companyoffic...triesfromaroundtheworld,Remedium,steampitchedtheir...LondonSchoolofBusiness. ,, Remedium( www.remedi...
(Date:11/25/2009)...,, NEWYORK,Nov.25/PRNewswire/--Reportlinker.c...initscatalogue: ,, UnitedStatesDentalDevicesMa...reportlinker.com/p0158733/United-States-Dental-Dev..., UnitedStatesDentalDevicesMarketAnalysisandFor...ssentialsourceforin-depthinformationanddatarelatin...
(Date:11/25/2009)...,, WALTHAM,Mass.,Nov.25/PRNewswire/--Accordin...onmedicaltechnologymarketintelligence,thenearly$3b...toseerapidgrowthoverthenextfiveyearsdespitetherece... 2010 reportfindsthatthismarketwillremainhighlydy...ngspecializeddevicesinpreviouslyunderservedsegment...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Reportlinker Adds Oncology Roadmap 3A Brand Spending Benchmarks and Market Forecast to 2013 61835 1Reportlinker Adds Oncology Roadmap 3A Brand Spending Benchmarks and Market Forecast to 2013 61835 2Reportlinker Adds Oncology Roadmap 3A Brand Spending Benchmarks and Market Forecast to 2013 61835 3Just like old times 3A Generating RNA molecules in water 10841 1Reportlinker Adds Toothpaste Global Market Trends 61832 1Reportlinker Adds Toothpaste Global Market Trends 61832 2Reportlinker Adds Toothpaste Global Market Trends 61832 3Reportlinker Adds Toothpaste Global Market Trends 61832 4Reportlinker Adds Toothpaste Global Market Trends 61832 5Reportlinker Adds Toothpaste Global Market Trends 61832 6Reportlinker Adds Toothpaste Global Market Trends 61832 7Reportlinker Adds Toothpaste Global Market Trends 61832 8Reportlinker Adds Toothpaste Global Market Trends 61832 9Reportlinker Adds Toothpaste Global Market Trends 61832 10
... Kiadis,Pharma announces today that the U.S. Food ...uct Reviroc(TM) Orphan Drug Designations (ODD) for...a (NHL). One ODD has been,granted for diffuse larg...ent,of follicular lymphoma. Reviroc(TM) is under d...m an autologous graft in bone marrow transplantati...
...ctivity Against Antibiotic Resistant Gram-Positive...NEW HAVEN, Conn., Dec. 8 Rib-X Pharmaceuticals, I...e company focused on the discovery, development an...reatment of antibiotic-resistant infections, today... clinical trial with the intravenous form of its n...
Other Medicine Technology:Kiadis Pharma Receives Two Orphan Drug Designations for Reviroc(TM) From the FDA 2Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 2Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 3Rib-X Pharmaceuticals Reports Positive Top-Line Results from Phase 2 Study of Delafloxacin 4
...powder reagent once reconstituted offers the labor...ty to help maximize laboratory productivity, minim...ound time. The proprietary technology of the Infin...helf life and stability once reconstituted that wi...
...nase powder reagent once reconstituted offers the ...ability to help maximize laboratory productivity, ...urnaround time. The proprietary technology of the ...s a long shelf life and stability once reconstitut...
Infinity™ Ammonia
Velo® 300M Wavefront Lens Analyzer
Medicine Products: